Qualigen Therapeutics, Inc. Share Price
NASDAQ: QLGN$0.00
+0.00 (0.00%) Qualigen Therapeutics, Inc. Stock Performance
Qualigen Therapeutics, Inc. Share Price Chart
$0.00$0.00
L
H
Qualigen Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Qualigen Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1 clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Qualigen Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
QLGN Share Price FAQs
What is Qualigen Therapeutics, Inc. share price today?
Qualigen Therapeutics, Inc. share price today is $0.00 as on September 19, 2026 at 12:44 pm IST.
What is the 52 week high and 52 week low of Qualigen Therapeutics, Inc. stock?
52 week high/low data for Qualigen Therapeutics, Inc. is currently unavailable.
What is QLGN's net income for the last quarter?
QLGN's net income for the last quarter is -0.00B USD.
Can I buy QLGN shares in India?
Yes. You can buy QLGN in India by opening an international trading account.